Show simple item record

dc.contributor.authorPellish, Randall
dc.date2022-08-11T08:08:14.000
dc.date.accessioned2022-08-23T15:47:36Z
dc.date.available2022-08-23T15:47:36Z
dc.date.issued2014-05-20
dc.date.submitted2014-09-12
dc.identifier.doi10.13028/8ncp-p366
dc.identifier.urihttp://hdl.handle.net/20.500.14038/28026
dc.description<p>Presented at the 2014 UMass Center for Clinical and Translational Science Research Retreat, held on May 20, 2014 at the University of Massachusetts Medical School, Worcester, Mass.</p>
dc.description.abstractMounting evidence suggests that particular aspects of human health and disease may be attributable to the trillions of microbes that inhabit our gastrointestinal tract, collectively referred to as the gut microbiota. Evidence suggests that pathologic changes to the microbiota (termed “dysbiosis”) are associated with a wide variety of medical outcomes, and therefore therapeutic manipulation of the microbiota is a major area of research interest. As part of the mini-symposium entitled "Manipulating the Gut Microbiome for Human Health," Dr. Pellish presents recent work related to fecal microbiota transplantation as a potentail treatment for Clostridium difficile colitis.
dc.formatyoutube
dc.language.isoen_US
dc.rightsCopyright the Author(s)
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/
dc.subjectmicrobiome
dc.subjectfecal microbiota transplantation
dc.subjectClostridium difficile infection
dc.subjectcolitis
dc.subjectBacterial Infections and Mycoses
dc.subjectDigestive System Diseases
dc.subjectGastroenterology
dc.subjectTranslational Medical Research
dc.titleRe-establishing the Balance of Nature in C. Diff with Fecal Microbiota Transplant
dc.typePresentation
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1227&amp;context=cts_retreat&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cts_retreat/2014/presentations/17
dc.identifier.contextkey6112698
refterms.dateFOA2022-08-23T15:47:37Z
html.description.abstract<p>Mounting evidence suggests that particular aspects of human health and disease may be attributable to the trillions of microbes that inhabit our gastrointestinal tract, collectively referred to as the gut microbiota. Evidence suggests that pathologic changes to the microbiota (termed “dysbiosis”) are associated with a wide variety of medical outcomes, and therefore therapeutic manipulation of the microbiota is a major area of research interest. As part of the mini-symposium entitled "Manipulating the Gut Microbiome for Human Health," Dr. Pellish presents recent work related to fecal microbiota transplantation as a potentail treatment for Clostridium difficile colitis.</p>
dc.identifier.submissionpathcts_retreat/2014/presentations/17


Files in this item

Thumbnail
Name:
Pellish.pdf
Size:
1.575Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright the Author(s)
Except where otherwise noted, this item's license is described as Copyright the Author(s)